Recordati Industria Chimica e Farmaceutica

Transaction in Own Shares • Jan 3, 2023

NEWS RELEASE

RECORDATI: UPDATE ON THE EXECUTION OF THE SHARE BUY-BACK PROGRAM

Milan, 3 rd January 2023 – Within the Recordati'sshare buy-back program communicated to the market and initiated on 20 th June 2022 , as per authorization granted by the Shareholders' Meeting held on 29 th April 2022, with the object of the servicing of current and future stock option plans in favour of Recordati Group's management or share-based incentive plans that should be approved by the Company in the future, the Company communicates the following purchase transactions of Recordati shares pursuant to art. 2, paragraph 3, of the EU Delegated Regulation 2016/1052/UE, on the basis of the information provided by UBS Europe SE as intermediary in charge of executing, in full independency, the share buy-back program on behalf of the Company.

Aggregate details of daily transactions made from 23rd December to 30th December 2022 in Recordati ordinary shares (ISIN IT0003828271) are as follows:

rd DECEMBER 2022 TO 30th DECEMBER SUMMARY OF PURCHASE TRANSACTIONS FROM 23 2022
Date	Type of	Quantity	Weighted average	Exchange
	Transaction		price
			(Euro)
23/12/2022	Purchase	1,459	38.8893	MTA
28/12/2022	Purchase	3,539	38.8156	MTA
TOTAL		4,998	38.8371

The details of all the purchase transactions carried out in the period indicated above are reported in the following pages.

On 30th December 2022, the Company held no. 3,689,033 treasury shares which amount to 1.764% of the current share capital.

Recordati, established in 1926, is an international pharmaceutical group, listed on the Italian Stock Exchange (Reuters RECI.MI, Bloomberg REC IM, ISIN IT 0003828271), with a total staff of more than 4,300, dedicated to the research, development, manufacturing and marketing of pharmaceuticals. Headquartered in Milan, Italy, Recordati has operations in Europe, Russia and the other C.I.S. countries, Ukraine, Turkey, North Africa, the United States of America, Canada, Mexico, some South American countries, Japan and Australia. An efficient field force of medical representatives promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in several therapeutic areas including a specialized business dedicated to treatments for rare diseases. Recordati is a partner of choice for new product licenses for its territories. Recordati is committed to the research and development of new specialties with a focus on treatments for rare diseases. Consolidated revenue for 2021 was € 1,580.1 million, operating income was € 490.2 million and net income was € 386.0 million.

For further information:

Recordati website: www.recordati.it

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.

Registered Office Via Matteo Civitali, 1 20148 Milano, Italy Ph. (39) 02 487871 Fax (39) 02 40073747 www.recordati.com Share Capital € 26.140.644,50 fully paid-up Milano, Monza, Brianza and Lodi Comp. Reg. No. 00748210150 Tax Code/VAT No. 00748210150 Milano R.E.A. No. 401832

Company subject to the Management and Coordination Activity of Rossini Luxembourg S.àr.l

Investor Relations Investor Relations Media Relations (39) 02 48787146 (39) 02 48787213 (39) 02 9288 6200 e-mail: investorelations@recordati.it e-mail: investorelations@recordati.it e-mail: recordati@brunswickgroup.com

Federica De Medici Lucia Abbatantuoni Brunswick: Barbara Scalchi / Andrea Mormandi

Attachment: Daily details of transactions

Trade Date	Trade Time	Currency	Exchange	Trade Price	Quantity
	(GMT)
23/12/2022	08:23:06	EUR	MTA	38,9100	77
23/12/2022	08:23:06	EUR	MTA	38,9100	72
23/12/2022	08:23:06	EUR	MTA	38,9300	66
23/12/2022	08:23:06	EUR	MTA	38,9300	83
23/12/2022	08:24:48	EUR	MTA	38,9000	132
23/12/2022	08:24:48	EUR	MTA	38,9000	20
23/12/2022	08:24:48	EUR	MTA	38,9000	123
23/12/2022	08:28:59	EUR	MTA	38,8800	131
23/12/2022	08:40:26	EUR	MTA	38,8200	149
23/12/2022	08:44:57	EUR	MTA	38,8500	139
23/12/2022	08:50:28	EUR	MTA	38,8900	18
23/12/2022	08:50:28	EUR	MTA	38,8900	125
23/12/2022	08:57:41	EUR	MTA	38,9000	25
23/12/2022	08:57:43	EUR	MTA	38,9000	24
23/12/2022	08:58:12	EUR	MTA	38,8900	3
23/12/2022	09:00:04	EUR	MTA	38,9100	6
23/12/2022	09:00:04	EUR	MTA	38,9100	21
23/12/2022	09:00:04	EUR	MTA	38,9100	24
23/12/2022	09:00:04	EUR	MTA	38,9100	90
23/12/2022	09:00:04	EUR	MTA	38,9000	72
23/12/2022	09:00:04	EUR	MTA	38,9000	59
28/12/2022	08:34:32	EUR	MTA	38,8300	130
28/12/2022	08:34:32	EUR	MTA	38,8400	134
28/12/2022	08:34:32	EUR	MTA	38,8400	8
28/12/2022	08:39:41	EUR	MTA	38,8200	19
28/12/2022	08:39:41	EUR	MTA	38,8200	118
28/12/2022	08:46:31	EUR	MTA	38,7900	54
28/12/2022	08:46:31	EUR	MTA	38,7900	96
28/12/2022	08:54:41	EUR	MTA	38,7800	144
28/12/2022	09:04:42	EUR	MTA	38,7200	128
28/12/2022	09:09:27	EUR	MTA	38,7500	131
28/12/2022	09:14:50	EUR	MTA	38,6500	32
28/12/2022	09:14:51	EUR	MTA	38,6500	103
28/12/2022	09:25:39	EUR	MTA	38,6700	129
28/12/2022	09:33:44	EUR	MTA	38,7000	21
28/12/2022	09:33:44	EUR	MTA	38,7000	30
28/12/2022	09:33:44	EUR	MTA	38,7000	30

28/12/2022	09:38:33	EUR	MTA	38,7400	61
28/12/2022	09:50:30	EUR	MTA	38,7200	132
28/12/2022	09:50:45	EUR	MTA	38,7000	129
28/12/2022	10:02:45	EUR	MTA	38,8000	136
28/12/2022	10:07:40	EUR	MTA	38,7400	143
28/12/2022	10:24:22	EUR	MTA	38,7300	146
28/12/2022	10:33:17	EUR	MTA	38,7900	103
28/12/2022	10:33:17	EUR	MTA	38,7800	134
28/12/2022	10:50:08	EUR	MTA	38,9100	122
28/12/2022	11:04:30	EUR	MTA	38,9400	20
28/12/2022	11:04:30	EUR	MTA	38,9400	122
28/12/2022	11:08:02	EUR	MTA	38,9300	136
28/12/2022	11:18:33	EUR	MTA	38,9100	138
28/12/2022	11:18:33	EUR	MTA	38,9100	8
28/12/2022	11:30:39	EUR	MTA	38,8500	84
28/12/2022	11:30:39	EUR	MTA	38,8500	1
28/12/2022	11:30:43	EUR	MTA	38,8500	48
28/12/2022	11:48:50	EUR	MTA	38,9200	145
28/12/2022	11:57:42	EUR	MTA	38,9600	137
28/12/2022	12:12:12	EUR	MTA	38,9600	20
28/12/2022	12:12:12	EUR	MTA	38,9600	126
28/12/2022	12:28:53	EUR	MTA	38,9600	141